Overall Technical outlook

Price Summary

Glenmark Pharmaceuticals Limited's stock started the year at 1876.4, climbed to a high of 1882.7, fell to 1855.4, and closed -0.77% down at 1861.9, with 247377 shares traded on 2025-10-17.
The stock's peak price over the last 52 weeks is 2226.7, with the lowest being 0.0.
GLENMARK's future price is expected to lie between 1500.0 and 2934.0, with an average expectation of 2253.6667, as per the recommendations of 12 analysts.

Technicals

Support and Resistance: The current price of 1861.9 for GLENMARK finds support at 1860.1 and resistance at 1940.9. These levels define a range in which the price might oscillate, with 1860.1 as a potential support and 1940.9 as a resistance level.
GLENMARK supportResistance c762fa
Support/Resistance for GLENMARK


Aroon: The AROON is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
GLENMARK aroon c762fa
Aroon chart for Glenmark Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
GLENMARK bbands c762fa
Bolinger Bands chart for Glenmark Pharmaceuticals Limited


Parabolic SAR: The PSAR maintains a bullish outlook, reinforcing a support level that could help uphold the market's upward trend. This suggests that the market is likely to continue climbing, with the support providing a solid base for further gains.
GLENMARK psar c762fa
Parabolic Stop and Reverse chart for Glenmark Pharmaceuticals Limited


Stochastic: The stochastic indicator shows a bullish trend for GLENMARK, with the K-line positioned above the D-line and surpassing the 80 level. This setup indicates strong upward momentum, suggesting that the market may continue its positive trajectory. Traders might view this as a sign of ongoing strength in the market.
GLENMARK stoch c762fa
Stochastic chart for Glenmark Pharmaceuticals Limited


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG is neutral for GLENMARK, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
GLENMARK trippleSMA c762fa
Tripple SMA chart for Glenmark Pharmaceuticals Limited


Before diving into the technical aspects of a company, such as stock price charts or volume trends, it's important to understand its fundamentals. These fundamentals include financial stability, growth potential, and strategic positioning. Additionally, knowing the broader industry landscape, including competitive pressures and regulatory factors, offers deeper insights. When this fundamental analysis is combined with technical indicators, it leads to more informed, accurate evaluations of the company's overall performance.